诺尔康：不断破局人工耳蜗市场

Core Viewpoint - Norkang has developed China's first domestically produced cochlear implant, significantly reducing costs and benefiting thousands of hearing-impaired individuals. The company aims to make cochlear implants affordable for more patients through technological breakthroughs [4][8]. Product Development - Norkang's latest cochlear implant, CS-30A, is the first in China to be fully compatible with 3.0T MRI scans, addressing a long-standing issue for patients [5]. - The company has introduced an integrated speech processor, "Qingting," which combines multiple components into a single device, improving user experience and addressing traditional device limitations [6]. - Norkang has developed a unique Chinese tone recognition algorithm, C-Tone, which enhances the recognition rates for Mandarin Chinese, achieving a 13.7% improvement for single syllables and an 18.6% improvement for double syllables [6]. Market Impact - Norkang's cochlear implants have been sold in nearly 30 countries, achieving a global market share ranking of third, with over 20,000 patients benefiting from the technology [4]. - The initial pricing of Norkang's cochlear implants was set at 78,000 yuan, significantly lower than imported alternatives, which has pressured foreign competitors to reduce their prices [8]. Supply Chain and Production - Norkang's cochlear implants have achieved a 95% localization rate in production, although some raw materials are still sourced from abroad. The company is actively working to establish a domestic supply chain for these materials [9]. - The company is collaborating with Zhejiang University to overcome challenges in material production, aiming for complete domestic sourcing within the next one to two years [9]. Future Innovations - Norkang is exploring advanced products, including a new auditory brainstem stimulator designed for patients with damaged auditory nerves, which has completed 30 clinical trials and is expected to launch next year [9]. - The company emphasizes the importance of continuous innovation and aims to maintain its leadership in the neuro-electronic technology sector [11].